References Regarding the Use of Antipsychotic Medications in Patients with Dementia

Brodaty H, Ames D, Snowdon J, et al. A randomized placebo–controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia. J Clin Psychiatry 2003; 64:134–43.

De Deyn PP, Rabheru K, Rasmussen A, et al. A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia. Neurology 1999;53:946955.

Gill SS, Bronskill SE, Normand SL, et al. Antipsychotic drug use and mortality in older adults with dementia. Ann Intern Med 2007;146:775–786.

Grace J, Daniel S, Stevens T, et al. Long–term use of rivastigmine in patients with dementia with Lewy bodies: An open–label trial. Int Psychogeriatr 2001;13:199–205.

Katz IR, Jeste DV, Mintzer JE, et al. Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: A randomized, double–blind trial. J Clin Psychiatry 1999;60:107–15.

Liperoti R. Gambassi G. Lapane KL, et al. Conventional and atypical antipsychotics and the risk of hospitalization for ventricular arrhythmias or cardiac arrest. Arch Intern Med 2005;165:696–701.

Parker C, Coupland C, Hippisley–Cox J. Antipsychotic drugs and risk of venous thromboembolism: nested case–control study. BMJ 2010;341:c4245 doi:10.1136/bmj.c4245 (online .pdf accessed Oct 25, 2010).

Rossom RC, Rector TS, Lederle FA, et al. Are all commonly prescribed antipsychotics associated with greater mortaility in elderly male veterans with dementia? J Am Geriatr Soc 2010;58:1027–34.

Schneeweiss S, Setoguchi S, Brookhart A, et al. Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patients. CMAJ 2007;176:627–632

Schneider LS, Tariot PN, Dagerman MS, et al, for the CATIE–AD Study Group. Effectiveness of atypical antipsychotic drugs in patients and Alzheimers disease. New Engl J Med 2006;355:1525–1538.

Sink KM, Holden KF, Yaffe K. Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence. JAMA 2005;293:596–608.